GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuformix PLC (LSE:NFX) » Definitions » LT-Debt-to-Total-Asset

Nuformix (LSE:NFX) LT-Debt-to-Total-Asset : 0.00 (As of Sep. 2022)


View and export this data going back to 2015. Start your Free Trial

What is Nuformix LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Nuformix's long-term debt to total assests ratio for the quarter that ended in Sep. 2022 was 0.00.

Nuformix's long-term debt to total assets ratio stayed the same from Sep. 2021 (0.00) to Sep. 2022 (0.00).


Nuformix LT-Debt-to-Total-Asset Historical Data

The historical data trend for Nuformix's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuformix LT-Debt-to-Total-Asset Chart

Nuformix Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial - - 0.01 - -

Nuformix Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Nuformix LT-Debt-to-Total-Asset Calculation

Nuformix's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2022 is calculated as

LT Debt to Total Assets (A: Mar. 2022 )=Long-Term Debt & Capital Lease Obligation (A: Mar. 2022 )/Total Assets (A: Mar. 2022 )
=0/4.976
=0.00

Nuformix's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2022 is calculated as

LT Debt to Total Assets (Q: Sep. 2022 )=Long-Term Debt & Capital Lease Obligation (Q: Sep. 2022 )/Total Assets (Q: Sep. 2022 )
=0/4.78
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nuformix  (LSE:NFX) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


Nuformix LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Nuformix's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Nuformix (LSE:NFX) Business Description

Traded in Other Exchanges
Address
60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR
Nuformix PLC is a pharmaceutical development company. It operates in the field of pharmaceutical development targeting unmet medical needs in fibrosis and oncology via drug repurposing. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, the company operates only in the UK.